CD163 and Lipedema: In lipedema, this inflammatory profile is further amplified by a phenotypic shift from anti-inflammatory M2 (CD163+) macrophages to M1 dominance, which accelerates fibrosis, impairs lymphatic flow, and fosters progressive adipose tissue dysfunction and metabolic deterioration [15,23,24,27].